Nrf2 upregulates ATP binding cassette transporter expression and activity at the blood-brain and blood-spinal cord barriers - Wikidata - wikimedia - TriplyDB

Nrf2 upregulates ATP binding cassette transporter expression and activity at the blood-brain and blood-spinal cord barriers

Nrf2 upregulates ATP binding cassette transporter expression and activity at the blood-brain and blood-spinal cord barriers

http://www.wikidata.org/entity/Q33770428

about

Redox Modulating NRF2: A Potential Mediator of Cancer Stem Cell Resistance Targeting transporters: promoting blood-brain barrier repair in response to oxidative stress injury In utero exposure to di-(2-ethylhexyl) phthalate induces testicular effects in neonatal rats that are antagonized by genistein cotreatment Tissue biodistribution of intravenously administrated titanium dioxide nanoparticles revealed blood-brain barrier clearance and brain inflammation in rat Nrf2 signaling increases expression of ATP-binding cassette subfamily C mRNA transcripts at the blood–brain barrier following hypoxia-reoxygenation stress Supplements, nutrition, and alternative therapies for the treatment of traumatic brain injury.Kinetic Modeling of ABCG2 Transporter Heterogeneity: A Quantitative, Single-Cell Analysis of the Side Population Assay.Role of Transporters in Central Nervous System Drug Delivery and Blood-Brain Barrier Protection: Relevance to Treatment of Stroke Regulation of ABC transporters at the blood-brain barrier.Altered Nrf2 signaling mediates hypoglycemia-induced blood-brain barrier endothelial dysfunction in vitro.In Vivo Imaging of Human MDR1 Transcription in the Brain and Spine of MDR1-Luciferase Reporter Mice.Regulation of ABC efflux transporters at blood-brain barrier in health and neurological disorders.Involvement of NRF2 Signaling in Doxorubicin Resistance of Cancer Stem Cell-Enriched Colonospheres.Ceramide 1-Phosphate Increases P-Glycoprotein Transport Activity at the Blood-Brain Barrier via Prostaglandin E2 Signaling.Efflux transporters in blood-brain interfaces of the developing brain Nrf2: a potential therapeutic target for naturally occurring anticancer drugs?ABCF2, an Nrf2 target gene, contributes to cisplatin resistance in ovarian cancer cells.Roles of aldo-keto reductases 1B10 and 1C3 and ATP-binding cassette transporter in docetaxel tolerance.Effect of Oxidative Stress on ABC Transporters: Contribution to Epilepsy Pharmacoresistance.Microglial Janus kinase/signal transduction and activator of transcription 3 pathway activity directly impacts astrocyte and spinal neuron characteristics.Astrocytes drive upregulation of the multidrug resistance transporter ABCB1 (P-Glycoprotein) in endothelial cells of the blood-brain barrier in mutant superoxide dismutase 1-linked amyotrophic lateral sclerosis.Age-dependent redox status in the brain stem of NO-deficient hypertensive rats.Triclosan Disrupts SKN-1/Nrf2-Mediated Oxidative Stress Response in C. elegans and Human Mesenchymal Stem Cells.NRF2 Is a Potential Modulator of Hyperresistance to Arsenic Toxicity in Stem-Like Keratinocytes Differential effects of c-myc and ABCB1 silencing on reversing drug resistance in HepG2/Dox cells.ABC Transporters in Cancer Stem Cells: Beyond Chemoresistance.PPAR-α, a lipid-sensing transcription factor, regulates blood-brain barrier efflux transporter expression.P-glycoprotein (ABCB1) and Oxidative Stress: Focus on Alzheimer's Disease.Selective induction of P-glycoprotein at the CNS barriers during symptomatic stage of an ALS animal model.Intranasal administration of vitamin D attenuates blood-brain barrier disruption through endogenous upregulation of osteopontin and activation of CD44/P-gp glycosylation signaling after subarachnoid hemorrhage in rats.Parthenolide prevents resistance of MDA-MB231 cells to doxorubicin and mitoxantrone: the role of Nrf2.Changes in metabolism affect expression of ABC transporters through ERK5 and depending on p53 status.Interindividual regulation of the BCRP/ABCG2 transporter in term human placentas.Blood-brain barrier disruption in diabetic mice is linked to Nrf2 signaling deficits: Role of ABCB10?Lysophosphatidic acid and amitriptyline signal through LPA1R to reduce P-glycoprotein transport at the blood-brain barrier.ATP Binding Cassette Sub-family Member 2 (ABCG2) and Xenobiotic Exposure During Early Mouse Embryonic Stem Cell Differentiation.In Vitro Modulation of Redox and Metabolism Interplay at the Brain Vascular Endothelium: Genomic and Proteomic Profiles of Sulforaphane Activity ATP-binding cassette transporters in progression and clinical outcome of pancreatic cancer: What is the way forward?

P2860

Q26774916-551B7616-804B-45F1-BA09-20215C1959C9 Q28088708-6101B7E9-01A9-46F5-8443-C5ABF8CD8009 Q28383987-98FDEB49-F459-4366-9BEC-2B4FB58611CF Q28387762-5287AE5B-533B-408B-B2B1-3A8AEE87F14E Q29247906-58AB5763-8529-4382-A152-9E36626382CE Q30393744-231B331C-E4B8-42E6-9766-4112B722E2AF Q32186144-B9516CAD-6545-4E99-80B0-B2DECE645555 Q33565967-618BC0C5-1D13-4ED9-9D04-EA6DF9B729AE Q35186642-E0759BCB-BD74-4646-A74A-EB5C29442115 Q35217471-B4BA6FD1-8DE3-4C39-B01A-9B532F8F7C67 Q36186153-0EE2A51F-9EE9-484C-AACA-B88F2AA15641 Q36378047-47CB3444-D8CC-467B-AC66-A737AE3D8DEF Q37235244-DD35FD64-B0F2-4807-B1D5-CC6E11724E49 Q37718541-562677B9-18C3-4E70-A7E8-757068CFF9AE Q38362582-0813B5D4-73C9-473A-8058-48828831F4C2 Q38694717-9742DA9C-E6B4-4F60-8284-1BB359DEF926 Q38719990-86C6762A-5430-49F0-B324-419DA8C4DE9D Q38746249-548F69DE-A352-465F-A5E0-09816B5A8C20 Q39164058-B4CC18F9-32D7-41B3-A984-28C9E39B5695 Q40462297-30A01AF4-6905-444B-825A-C8C23232DE38 Q41231187-D6D33606-2D0A-427D-B849-D8EAC9F623AD Q41274362-75AF3A0A-4950-48DE-97C2-50BE6770CFF3 Q42282592-E1ADECB1-B74F-4D46-8FD4-8D8F5EA0D883 Q42730519-AB104C6F-056F-45C7-BE14-B334CE432663 Q46927619-42BA246A-8D42-4BDD-93CF-3427F2308F74 Q47118535-97F6FF13-E4F5-4C92-BD47-DDCA93DC2C95 Q47710625-22C2094F-E838-4FF2-BBB0-72CEDDCE8D42 Q47873232-BE0D0DF8-509A-4A59-98C4-90EEF3D989F3 Q48384156-E2C0AE9A-DB81-4C0B-BEC8-4B126965764F Q48495346-3B86F963-D76D-4F1B-AA44-BBAA0B611DBC Q49193135-27CB6305-8086-49DE-9167-7827E97F58FA Q49303366-8B8B6B91-8194-4DC1-8EBC-D76607087262 Q49546188-3A7F659A-DA2C-4F0E-A98A-13F77B9EBB4F Q50964354-BFA2D220-4C3E-446B-8B91-1CF5FEF89B7E Q51032610-97B53DE1-980F-46A5-BD3E-6454BA4910E6 Q54104981-81560CF2-036E-4706-9B05-C98BEF1C1C1E Q58714736-5B4893D3-43BA-445E-89F0-BC61DA3267DC Q58798114-94414AC6-6DD3-4349-91E8-A54919B65805

P2860

Nrf2 upregulates ATP binding cassette transporter expression and activity at the blood-brain and blood-spinal cord barriers

http://www.wikidata.org/entity/Q33770428

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

name

Nrf2 upregulates ATP binding c ...... and blood-spinal cord barriers

@ast

Nrf2 upregulates ATP binding c ...... and blood-spinal cord barriers

@en

type

label

Nrf2 upregulates ATP binding c ...... and blood-spinal cord barriers

@ast

Nrf2 upregulates ATP binding c ...... and blood-spinal cord barriers

@en

prefLabel

Nrf2 upregulates ATP binding c ...... and blood-spinal cord barriers

@ast

Nrf2 upregulates ATP binding c ...... and blood-spinal cord barriers

@en

P1433

Q33770428-2BF5F509-665C-432F-8911-DF52D31B1370

P1476

Q33770428-90832ADC-50EE-4D63-AD40-36599E345EC5

P2093

Q33770428-0E3ECE7F-3FCA-48AA-8E87-AE0229D84AC7

Q33770428-2F3F6CF8-731E-40C5-90FD-CBA484342172

Q33770428-75D2EF30-07FB-4BDF-AF5F-46C3612FB9E6

Q33770428-9537BF9F-0169-4362-A7DD-702E4F36B438

Q33770428-A47F32CB-92E1-411E-884D-5F32DC12F433

Q33770428-B1112488-0632-46E6-8607-4C18890EA099

P2860

Q33770428-05173B51-5706-4C72-BA27-47A802B271B5

Q33770428-05556F31-7A67-4CF7-88A7-79F534B45753

Q33770428-07D0528F-A6F2-41D9-B8F8-22F663BED1AC

Q33770428-1AF4A422-631C-4201-893C-92226E3912AB

Q33770428-1C148158-D6F5-430D-8A56-58406D05BCE4

Q33770428-2CE68F29-DEC6-4E71-A874-0D5ECBFB03EA

Q33770428-2EC2246F-0D3D-477B-B4C1-EDF6F667321A

Q33770428-3481F29B-9CEC-4CDC-9617-AADFF2C52A7D

Q33770428-3C454710-ABF4-4422-BE89-9BDC859044C7

Q33770428-3F8412B7-9B16-4069-A239-981740F39CE6

P304

Q33770428-528AF770-F4D6-4A35-B218-97B9CBA3824D

P31

Q33770428-912C3DE7-1802-4ADC-8076-38D01295ADC3

P356

Q33770428-3C9697CB-4AD3-4003-8435-F716C127D040

P407

Q33770428-D39E3437-4053-40DE-B969-DEF8EE0527BC

P433

Q33770428-E9317137-4E94-4943-B947-8CC384695402

P478

Q33770428-BF35517D-71E8-42BC-9A65-3C51F25D7350

P50

Q33770428-25273974-0DFB-4A3D-9F0F-3ECDE64A0D79

P577

Q33770428-94FB2310-BBA4-41EF-9092-65A1EEAB9DFA

P698

Q33770428-076C896F-D4E1-4EAC-817A-4886595FA771

P932

Q33770428-65C6A3CB-CEBF-4DF3-BFE8-FB3D262E1F7E

P356

JNEUROSCI.2935-13.2014

P1433

Journal of Neuroscience

P1476

Nrf2 upregulates ATP binding c ...... and blood-spinal cord barriers

@en

P2093

Christopher R Campos

http://www.w3.org/2001/XMLSchema#string

Jessica L Boni

http://www.w3.org/2001/XMLSchema#string

John C Peart

http://www.w3.org/2001/XMLSchema#string

Lindsay K Smith

http://www.w3.org/2001/XMLSchema#string

Ronald E Cannon

http://www.w3.org/2001/XMLSchema#string

Xueqian Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Does Nrf2 contribute to p53-mediated control of cell survival and death?

Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis

When NRF2 talks, who's listening?

Coordinated nuclear receptor regulation of the efflux transporter, Mrp2, and the phase-II metabolizing enzyme, GSTpi, at the blood-brain barrier

ABC transporter function and regulation at the blood-spinal cord barrier

Rapid, reversible modulation of blood-brain barrier P-glycoprotein transport activity by vascular endothelial growth factor.

Regulation of P-glycoprotein and other ABC drug transporters at the blood-brain barrier

Xenobiotic transport across isolated brain microvessels studied by confocal microscopy.

Constitutive androstane receptor-mediated up-regulation of ATP-driven xenobiotic efflux transporters at the blood-brain barrier.

Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis.

P304

8585-8593

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1523/JNEUROSCI.2935-13.2014

http://www.w3.org/2001/XMLSchema#string

P407

P433

25

http://www.w3.org/2001/XMLSchema#string

P478

34

http://www.w3.org/2001/XMLSchema#string

P50

David S. Miller

P577

2014-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24948812

http://www.w3.org/2001/XMLSchema#string

P932

4061395

http://www.w3.org/2001/XMLSchema#string